Hypereosinophilic syndrome: endomyocardial fibrosis.
Pitt
M
M
Department of Cardiology, University Hospital NHS Trust, Selly Oak Hospital, Birmingham, UK.
Davies
M K
MK
Brady
A J
AJ
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D002074:Butanones / Q000009:adverse effects*; D004719:Endomyocardial Fibrosis / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000473:pathology; D005260:Female; D006321:Heart / Q000000981:diagnostic imaging; D006801:Humans; D017681:Hypereosinophilic Syndrome / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000473:pathology; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D009206:Myocardium / Q000473:pathology; D000077430:Nabumetone; D011859:Radiography
D000894:Anti-Inflammatory Agents, Non-Steroidal; D002074:Butanones; D000077430:Nabumetone